We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
60.00 | 2.69% | 2,290.00 | 2,250.00 | 2,300.00 | 2,280.00 | 2,210.00 | 2,210.00 | 82,948 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 174.02M | 9.23M | 0.2626 | 86.63 | 799.83M |
TIDMCRW
RNS Number : 3280T
Craneware plc
13 November 2019
Craneware plc
Result of AGM
13 November 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed.
Following the close of the meeting, Ron Verni, Non-executive Director, has temporarily taken the role of Interim Chairman until Will Whitehorn assumes the role of Chairman of the Board on 1 January 2020, as described in the AGM Statement released yesterday.
The proxy voting results are included below.
Resolution For Against Discretion Withheld Total to Chairman and Third party 01 17,146,910 0 0 7,211 17,154,121 ----------- ---------- ----------------- --------- ----------- 02 16,557,831 595,563 0 727 17,154,121 ----------- ---------- ----------------- --------- ----------- 03 12,434,608 4,601,250 0 118,263 17,154,121 ----------- ---------- ----------------- --------- ----------- 04 17,119,616 33,979 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 05 17,117,165 36,430 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 06 13,139,798 4,013,797 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 07 17,122,584 31,011 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 08 17,153,595 0 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 09 12,276,731 4,876,663 0 727 17,154,121 ----------- ---------- ----------------- --------- ----------- 10 16,153,986 998,429 1,180 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 11 17,147,775 5,820 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 12 16,056,496 1,097,099 0 526 17,154,121 ----------- ---------- ----------------- --------- ----------- 13 16,950,177 200,450 0 3,494 17,154,121 ----------- ---------- ----------------- --------- -----------
Resolutions 3, 6 and 9
The Board of Directors notes that while Resolutions 3, 6 and 9 were passed and a majority of over 71% of the proxy votes received were 'for' each of these resolutions, a number of the proxy votes received opposed these resolutions.
We will consult with our shareholders in order to understand more fully the reasons for their votes in regard to these resolutions and we will reflect carefully on feedback received from our shareholders.
An update on the consultation process will be made, in accordance with the UK Corporate Governance Code, within six months of the AGM.
For further information, please contact:
Craneware plc Peel Hunt (NOMAD & Joint Investec Bank (Joint Alma (Financial Broker) Broker) PR) +44 (0)131 550 +44 (0)203 405 3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 0205 Keith Neilson, Dan Webster Patrick Robb Caroline Forde CEO Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan CFO Guy Pengelley Henry Reast Helena Bogle
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGBLBDBLGBBGCX
(END) Dow Jones Newswires
November 13, 2019 11:10 ET (16:10 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions